Results 51 to 60 of about 54,860 (296)

A Bibliometric Analysis of Global Research on Japanese Encephalitis From 1934 to 2020

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Japanese encephalitis (JE) is a mosquito-borne disease caused by the Japanese encephalitis virus (JEV). The disease is mainly an epidemic in Asia and has been studied for nearly 90 years.
Chongxiao Xu   +13 more
doaj   +1 more source

Japanese encephalitis [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2013
Japanese encephalitis (JE) is an infectious disease of the central nervous system caused by Japanese encephalitis virus (JEV), a zoonotic mosquito-borne flavivirus. JEV is prevalent in much of Asia and the Western Pacific, with over 4 billion people living at risk of infection.
Sang-Im Yun, Young-Min Lee
openaire   +2 more sources

Emergence or improved detection of Japanese encephalitis virus in the Himalayan highlands? [PDF]

open access: yes, 2016
The emergence of Japanese encephalitis virus (JEV) in the Himalayan highlands is of significant veterinary and public health concern and may be related to climate warming and anthropogenic landscape change, or simply improved surveillance. To investigate
Barker, Christopher M   +7 more
core   +1 more source

Japanese Encephalitis

open access: yesJournal of Special Operations Medicine, 2016
Abstract: Japanese encephalitis (JE) is an acute infective disease in the central nervous system. Pigs and birds are the main reservoirs of JE viruses, albeit, there is no transmission from human to human with mosquito bites. Clinical manifestations of JE in human vary from mild symptoms like rhinitis until severe symptoms, and even death.
openaire   +5 more sources

Clinical profile and outcome of acute encephalitis syndrome (AES) patients treated in College of Medical Sciences-Teaching Hospital

open access: yesJournal of College of Medical Sciences-Nepal, 2014
Objective: Acute encephalitis syndrome is a cause of significant morbidity and mortality in Nepal. Although Japanese encephalitis virus (JEV) was thought to be a major cause for acute encephalitis syndrome, more non-Japanese encephalitis virus cases
Lekhjung J Thapa   +6 more
doaj   +1 more source

Japanese SimCSE Technical Report [PDF]

open access: yesarXiv, 2023
We report the development of Japanese SimCSE, Japanese sentence embedding models fine-tuned with SimCSE. Since there is a lack of sentence embedding models for Japanese that can be used as a baseline in sentence embedding research, we conducted extensive experiments on Japanese sentence embeddings involving 24 pre-trained Japanese or multilingual ...
arxiv  

Japanese encephalitis: Challenges and intervention opportunities in Nepal [PDF]

open access: yesVeterinary World, 2015
Japanese encephalitis (JE) is a mosquito borne zoonotic disease caused by JE virus (JEV). JE has been endemic in Terai region, the lowland plains of Nepal bordering India, since 1978.
Shristi Ghimire , Santosh Dhakal
doaj   +1 more source

Studies on Complement Fixation Test in a Mouse Immuni­zed with Japanese B Encephalitis Virus. [PDF]

open access: yes, 1952
1) I designed a new micro-method for complement fixation test by means of a capillary pipette. 2) By this method, the complement-fixing antibodies in an individual mouse could be tested without taking its life.
Hioka, T.
core   +1 more source

Mixed Upper and Lower Motor Neuron Damage in Japanese Encephalitis Virus Infection

open access: yesCase Reports in Neurology, 2020
Cerebral manifestations in Japanese B encephalitis are well known. However, there are very few studies focusing on extra-cerebral manifestations, among which focal anterior horn cell involvement is exceedingly rare.
Ritwik Ghosh   +4 more
doaj   +1 more source

Combined Systemic Immunotherapy and Intrathecal Dexamethasone in Febrile Infection Related Epilepsy Syndrome

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Febrile infection related epilepsy syndrome (FIRES) is a rare presentation of refractory status epilepticus with immune dysregulation as a potential pathologic mechanism. Despite promising results from second‐line immunomodulators, approximately 30% remain refractory to treatment.
Kristen S. Fisher   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy